Dynorphins are a class of very potent opioid peptides with wide distribution in the central and peripheral nervous systems. Dynorphins may act both as neurotransmitters or neuromodulators in brain and as hormones in the endocrine system. They are thought to be involved in pain perception, intestinal peristalsis, feeding and sleep. Dynorphins are synthesized as a precursor protein, prodynorphin, that through limited proteolysis by trypsin-like and carboxypeptidase B-like enzymes gives rise to alpha- and beta-neoendorphin. dynorphins A, A-8 and B, leumorphin, and leucine-enkephalin. These prodynorphin derived peptides bind to the various opiate receptors with different affinities, and so the processing enzymes play a key role in the modulation of opioid gene expression. However, little is known about the endopeptidase processing enzymes. The objective of this study will be to purify and characterize a novel enzyme involved in prodynorphin processing. A dynorphin processing enzyme that acts at a monobasic cleavage site has previously been reported Further studies described in this proposal include: purification and characterization of the enzyme, cellular and subcellular localization, development of site-directed inhibitors, and development of monoclonal and/or polyclonal antibodies. Regulation of this enzyme will be examined in several neural and endocrine cell lines. Information gained through these studies on the processing enzymes should serve not only as a basis for future investigations of dynorphin synthesis but also should aid in the study of other neuropeptide processing pathways.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29NS026880-03
Application #
3477636
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Project Start
1989-08-01
Project End
1994-07-31
Budget Start
1991-08-01
Budget End
1992-07-31
Support Year
3
Fiscal Year
1991
Total Cost
Indirect Cost
Name
New York University
Department
Type
Schools of Medicine
DUNS #
004514360
City
New York
State
NY
Country
United States
Zip Code
10012
Pena, Darlene Aparecida; Andrade, Victor Piana de; Silva, Gabriela Ávila Fernandes et al. (2016) Rational design and validation of an anti-protein kinase C active-state specific antibody based on conformational changes. Sci Rep 6:22114
Gomes, Ivone; Ayoub, Mohammed Akli; Fujita, Wakako et al. (2016) G Protein-Coupled Receptor Heteromers. Annu Rev Pharmacol Toxicol 56:403-25
Stockton Jr, Steven D; Gomes, Ivone; Liu, Tong et al. (2015) Morphine Regulated Synaptic Networks Revealed by Integrated Proteomics and Network Analysis. Mol Cell Proteomics 14:2564-76
Gupta, A; Fujita, W; Gomes, I et al. (2015) Endothelin-converting enzyme 2 differentially regulates opioid receptor activity. Br J Pharmacol 172:704-19
Gupta, Achla; Gomes, Ivone; Wardman, Jonathan et al. (2014) Opioid receptor function is regulated by post-endocytic peptide processing. J Biol Chem 289:19613-26
Toniolo, Elaine F; Maique, Estêfani T; Ferreira Jr, Wilson A et al. (2014) Hemopressin, an inverse agonist of cannabinoid receptors, inhibits neuropathic pain in rats. Peptides 56:125-31
Gomes, Ivone; Aryal, Dipendra K; Wardman, Jonathan H et al. (2013) GPR171 is a hypothalamic G protein-coupled receptor for BigLEN, a neuropeptide involved in feeding. Proc Natl Acad Sci U S A 110:16211-6
Miller, Lydia K; Hou, Xiaowen; Rodriguiz, Ramona M et al. (2011) Mice deficient in endothelin-converting enzyme-2 exhibit abnormal responses to morphine and altered peptide levels in the spinal cord. J Neurochem 119:1074-85
Morgan, Daniel J; Wei, Suwen; Gomes, Ivone et al. (2010) The propeptide precursor proSAAS is involved in fetal neuropeptide processing and body weight regulation. J Neurochem 113:1275-84